2A INFRON ALPHA 3MIU Injection 1s

 1,090.00

Manufactured by:
Active Pharmaceutical Ingredient:
Drug Strength: 3miu
Drug Form : Injection
Pack Size : 1s
Does this requires a prescription ?Yes

Interferon Alpha 2a:3MIU | Corticosteroids systemic

Alternate brands

  • LAIFULONG 3MIU Injection Vial
     600.00
  • You can save 490
  • BLAUFERON B 3MIU Injection 1s
     600.00
  • You can save 490
  • CELL-AID 3MIU Injection Vial
     570.00
  • You can save 520

    Manufactured / Marketed By : R.YProduct Form : InjectionPack Size : 1sIngredients : Interferon Alpha 2a:3MIUGeneric Category : Corticosteroids systemic

    Reviews

    There are no reviews yet.

    Be the first to review “2A INFRON ALPHA 3MIU Injection 1s”

    How it works

    2A INFRON ALPHA 3MIU Injection 1s work by affecting cell function/growth and the body's natural defenses (immune system) in many ways.

    Side effects

    Major & minor side effects for 2A INFRON ALPHA 3MIU Injection 1s

    • Depression
    • Difficulty in breathing
    • Swelling or puffiness of face
    • Thyroid imbalances
    • Decrease in blood cell ount
    • Loss of appetite
    • Headache
    • Dizziness
    • Dry mouth
    • Blurred vision
    • Nausea and vomiting
    • Weight loss

    Uses of 2A INFRON ALPHA 3MIU Injection 1s

    What is it prescribed for?

    • Hairy Cell Leukemia

      This medicine is used to treat hairy cell leukemia which is a rare, slow-growing cancer of the bone marrow and produces too many white blood cells (B lymphocytes). These excess B cells are abnormal and look "hairy" under a microscope.

    • Kaposi's Sarcoma

      This medicine is used in the treatment of Kaposi's Sarcoma which is a type of tumor that develops from the cells that line lymph or blood vessels secondary to AIDS.

    • Multiple Myeloma

      This medicine is used in the treatment of Multiple Myeloma which is a type of blood cancer which affects white blood cells.

    • Malignant Melanoma

      This medicine is used in the treatment of Malignant Melanoma which is a type of skin cancer.

    • Chronic myelogenous leukemia (CML)

      This medicine is used in the treatment of is a type of cancer of the blood and bone marrow which affects all the white blood cells except lymphocytes.

    • Chronic Hepatitis C

      This medicine is used to treat chronic hepatitis C which is a liver disease caused by hepatitis C virus (HCV).

    • Chronic Hepatitis B

      This medicine is used to treat chronic hepatitis B which is a liver disease caused by hepatitis B virus (HBV).

    • Non-Hodgkin's Lymphoma

      This medicine is used in the treatment of Non-Hodgkin's Lymphoma which is a cancer of the lymphatic system which affects a type of white blood cells called lymphocytes.

    • Genital warts

      This medicine is used in the treatment of Genital warts which is a sexually transmitted skin disease caused by the Human Papilloma Virus (HPV).

    Concerns

    Frequently asked questions

    • Onset of action

      The peak effect of this medicine can be observed within 3-12 hours of intramuscular or subcutaneous dose and 30 minutes followed by an intravenous administration of the dose.

    • Duration of Effect

      The amount of time for which this medicine remains active in the body is not clinically established.

    • Safe with Alchohol?

      Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

    • Is it habit forming?

      No habit-forming tendencies were reported.

    • Usage in pregnancy?

      This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

    • Usage while breast-feeding?

      This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition

    When not to use?

    • Allergy

      This medicine is not recommended for use in patients with a known allergy to 2A INFRON ALPHA 3MIU Injection 1s or any other inactive ingredients present along with it.

    • Autoimmune hepatitis

      This medicine is not recommended for use in patients with autoimmune hepatitis due to the increased risk of worsening of the patient's condition.

    • Decompensated Liver Disease

      This medicine is not recommended for use in patients with decompensated liver disease due to the increased risk of worsening of the patient's condition.

    Warnings

    Warnings for special population
    • Pregnancy

      This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine.

    • Breast-feeding

      This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before receiving this medicine. Your doctor may advise you to discontinue the drug or to discontinue breastfeeding based on your clinical condition

    General Warnings
    • Severe allergic reactions

      This medicine may cause severe allergic reactions. In case of any such reactions, treatment should be discontinued and appropriate medical therapy should be instituted immediately.

    • Psychiatric problems

      Use of this medicine can cause life-threatening or fatal neuropsychiatric reactions. These include suicide, suicidal tendency, depression, and an increased risk of relapse of recovering drug addicts. Educate the patients and their caregivers to report any symptoms of depression or suicidal tendency to the doctor so that counseling and monitoring of progress can be performed at regular intervals.

    • Bone marrow suppression

      Use of this medicine can cause bone marrow depression. Severe decreases in white blood cell or platelet counts have been reported with this medicine. Close monitoring of blood cell count and symptoms for any infections should be monitored. Appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • Autoimmunity

      The use of this medicine can develop different auto-antibodies in the body which may lead to various autoimmune disorders. Close monitoring of symptoms, auto-antibodies, and TSH levels are recommended.

    • Growth retardation in pediatric patients

      Weight loss and growth inhibition reported during combination therapy in pediatric patients.

    • Heart diseases

      This medicine should be used with caution in patients with cardiac dysfunctions such as hypertension, arrhythmias, angina, myocardial infarction, cardiomyopathy, and congestive heart failure due to increased risk of worsening of the patient's condition. Close monitoring of cardiac function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • Lung toxicity

      This medicine should be used with caution in patients with lung diseases since it may worsen the condition. Report any symptoms like breathing difficulty, pulmonary infiltrates, pulmonary hypertension, interstitial pneumonitis, pneumonia, bronchiolitis obliterans, etc to your doctor on priority. Close monitoring of lung function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • Contraception

      Use of this medicine in combination with ribavirin may increase the risk of harm to the unborn baby in pregnant women. Effective contraception is advised for the men with female partners and women with the childbearing potential to avoid such risks. Birth controls should be administered while receiving this medicine and for 4-7 months post-therapy to prevent the pregnancy.

    Dosage

    • Missed Dose

      Since this medicine is administered in a healthcare setup the chances of missed dose are less. The missed dose of this medicine should be administered as soon as possible. It is advisable to skip the missed dose if it is already the time for your next scheduled dose. Do not double the dose to make up for the missed dose.

    • Overdose

      Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

    Interactions

    Interaction with Medicines
    • Tramadol severe
    • Zidovudine severe
    • Bexarotene severe
    • Clozapine severe
    • Deferiprone severe
    Disease interactions
    • severe

      This medicine should be used with caution in patients with renal dysfunction due to increased risk of worsening of the patient's condition. Close monitoring of renal function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • severe

      This medicine should be used with extreme caution or should be avoided in patients with autoimmune diseases due to increased risk of worsening of the patient's condition. Close monitoring, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • severe

      This medicine should be used with caution in patients with liver dysfunction due to increased risk of worsening of the patient's condition. Close monitoring of liver function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • severe

      This medicine should be used with caution in patients with cardiac dysfunctions such as hypertension, arrhythmias, angina, myocardial infarction, cardiomyopathy, and congestive heart failure due to increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor on priority. Close monitoring of cardiac function, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • severe

      This medicine should be used with caution in patients with seizures, psychiatric disorders or conditions affecting posture or gait due to increased risk of worsening of the patient's condition. Report any unusual symptoms to the doctor on priority. Close monitoring, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • severe

      Thyroid disorders

    • moderate

      This medicine should be used with caution in patients with diabetes mellitus due to increased risk of precipitation of ketoacidosis. Close monitoring of blood glucose, appropriate dose adjustments or replacement with a suitable alternative may be required in some cases based on the clinical condition.

    • moderate

      This medicine should be used with caution in patients suffering from bone marrow suppression due to the increased risk of worsening of the patient's condition. Close clinical monitoring of hematopoietic function is recommended. An alternative treatment option should be considered in some cases based on the clinical condition.

    General Instructions

    Administer this medicine as advised by the doctor. It should be given in multiple cycles along with other antiviral agents. It is important to receive every scheduled dose. The blood cells, liver function, CNS disorders, cardiac function, renal function should be assessed before starting the treatment. Any signs and symptoms of psychiatric, heart and liver dysfunction should be reported to the doctor on priority.

    Other details

    • Usage does not depend on food timings
    • To be taken as instructed by doctor
    • May cause sleepiness

    References

    Additional Information>

    One of the following licensed pharmacy from the nearest location will deliver 2A INFRON ALPHA 3MIU Injection 1s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.

    Questions and Answers

    There are no questions yet. Be the first to ask a question about this product.

    Only registered users are eligible to enter questions

    Medicalstore.com.pk © All rights reserved

    Made with ❤ by Dairah

    Shopping Cart